United Kingdom›Wastewater
Sources & methods↗
Home Office WAND · experimental statistics

Wastewater analysis

Estimated consumption gives a different view from surveys, treatment and policing: it measures drug residues across sampled wastewater systems.

Published England sample42 sites28% of the population
Historical Scotland coverage46%Population covered in published phase 3
Published phase 350 sitesAcross England and Scotland
Published programme scope28Substances, including 22 synthetic opioids
ScotlandExperimental evidence
Historical WAND coverage; no current programme

Eight Scottish sites contributed to the published August 2024–July 2025 evidence. Home Office funding for Scottish sites was withdrawn in late 2025, and the Scottish Government confirmed in August 2026 that no illicit-drug wastewater monitoring was currently operational in Scotland.

Historical WAND findings remain valid for their stated period; there is no current Scottish sampling programmeOpen status source ↗
Northern IrelandCoverage gap
No comparable public drug series

Northern Ireland was not included in the Home Office WAND programme. No comparable official public wastewater dataset on illicit-drug consumption was located, so no Northern Ireland estimate is presented.

National estimates

Estimated annual consumption in England

Purity-adjusted central estimates · August 2024 to July 2025

Cocaine123,000kg£9.8bn · CI ±39,400kg
Amphetamine46,700kg£0.5bn · CI ±22,200kg
Ketamine30,800kg£0.9bn · CI ±26,400kg
MDMA9,900kg£0.3bn · CI ±6,700kg
Heroin6,800kg£0.3bn · CI ±6,100kg
Methamphetamine2,300kg£0.2bn · CI ±1,700kg
▦ Home Office WAND◷ Aug 2024–Jul 2025ExperimentalOpen source ↗
Trend signal

Change from 2021 to 2025

Comparable 16-site trend series covering 18% of England

Cocaine+26%January–April 2021 compared with January–April 2025
Amphetamine-27%January–April 2021 compared with January–April 2025
Ketamine+229%January–April 2021 compared with January–April 2025
MDMA+232%January–April 2021 compared with January–April 2025
Heroin-40%January–April 2021 compared with January–April 2025
Methamphetamine+61%January–April 2021 compared with January–April 2025
▦ Home Office WAND◷ Jan–Apr comparisonExperimentalOpen source ↗
02

Geographical pattern

Areas repeatedly identified as higher or lower within sampled WAND locations

England and Scotland

Reported high and low consumption signals

August 2024 to July 2025 · not a complete regional league table

DrugHigher estimated consumptionLower estimated consumption
CocaineNorth East (site), North West (site), ScotlandYorkshire and the Humber
KetamineEast of England (site), North West (site), South East, South West (site)East Midlands, West Midlands, Scotland
HeroinScotland, West Midlands, East of EnglandLow estimates cannot be interpreted because 6-MAM is unstable
AmphetamineNorth West, East of EnglandSouth East (site), Yorkshire and the Humber
MDMALondon, North West (site), South East (site), South WestNorth East
MethamphetamineEast of England (site), London, North West (site), South East (site), South West, West Midlands (site), Yorkshire and the Humber (site)Rural areas and small cities
Site qualifier

“(site)” means one sampled treatment plant showed the pattern. An unqualified region means several sites showed it consistently. Urban areas were more prominent for cocaine, MDMA and methamphetamine.

▦ Home Office WAND◷ Phase 3 · Aug 2024–Jul 2025Open source ↗
03

Weekly pattern and method

What the signal can show — and what it cannot

Weekend-weighted

MDMA and cocaine

Higher estimated consumption at weekends and lower levels on weekdays. MDMA has a Monday–Tuesday tail because excretion can take one to two days.

More even through the week

Ketamine, amphetamine and methamphetamine

These substances showed a steadier weekly pattern, which can support monitoring of more regular consumption.

No clear weekly pattern

Heroin

The 6-MAM biomarker is unstable, so low estimates and day-to-day patterns require particular caution.

Sampling rhythm

Seven-day windows

Each site provides 24-hour composite samples for seven consecutive days, asynchronously once every two months.

01Collect

Take 24-hour composite samples at wastewater treatment plants.

02Measure

Test for drugs and human metabolites such as benzoylecgonine and norketamine.

03Back-calculate

Adjust for flow, metabolism, deposition and retail purity.

04Model

Extrapolate England estimates with uncertainty intervals; Scotland is not nationally extrapolated.

Experimental
Use with care

WAND cannot identify how many people used a drug, who used it, individual purity, or whether every detected amount was consumed. Cannabis is not measured. Limited nitazene detection does not demonstrate absence of use. Wales and Northern Ireland were outside this programme, and national extrapolation currently applies to England only.

Open WAND collection ↗
UK Drug Trends Intelligence

TD Consultancy · Latest available data, provisional statistics, experimental estimates and operational intelligence are labelled separately · Verify decisions against the linked primary evidence.